Skip to main content
Premium Trial:

Request an Annual Quote

Arkansas Myeloma Institute Gets $4.5M Gift to Build Mass-Spec Lab

NEW YORK (GenomeWeb News) — The University of Arkansas for Medical Sciences has received a $4.5 million endowment to establish a lab to conduct genomic and proteomic studies of multiple myeloma, or cancer of the bone marrow, the school said today.
The commitment from Stephen and Nancy Grand to the university’s Myeloma Institute for Research and Therapy will be used to establish a mass-spectrometry lab to analyze proteins that are produced by myeloma tumor cells and bone marrow cells.
Stephen Grand, a patient at the Myeloma Institute since 2006, also donated $300,000 last year with his wife to help the institute develop ellipticine, a plant-derived alkaloid that is a potential therapeutic agent.
The school said the studies “are expected to clarify key disease mechanisms and details about myeloma that will be translated into clinical care.”
The new lab, called the Nancy and Stephen Grand Laboratory for Myeloma Proteomics, will be headed by Ricky Edmondson. It will be located at UAMS’ Arkansas Cancer Research Center, located in Little Rock.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.